EGLN1 Antikörper (AA 272-355)
Kurzübersicht für EGLN1 Antikörper (AA 272-355) (ABIN565755)
Target
Alle EGLN1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 272-355
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant EGLN1.
-
Sequenz
- LMSSMDDLIR HCNGKLGSYK INGRTKAMVA CYPGNGTGYV RHVDNPNGDG RCVTCIYYLN KDWDAKVSGG ILRIFPEGKA QFAD
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- EGLN1 (NP_071334, 272 a.a. ~ 355 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response." in: Cancer research, Vol. 69, Issue 2, pp. 616-24, (2009) (PubMed).
: "
-
Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response." in: Cancer research, Vol. 69, Issue 2, pp. 616-24, (2009) (PubMed).
-
- EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1))
-
Andere Bezeichnung
- EGLN1
-
Hintergrund
-
Full Gene Name: egl nine homolog 1 (C. elegans)
Synonyms: C1orf12,DKFZp761F179,ECYT3,HIFPH2,HPH2,PHD2,SM-20,SM20,ZMYND6 -
Gen-ID
- 54583
-
NCBI Accession
- NM_022051
-
Pathways
- cAMP Metabolic Process, Warburg Effekt
Target
-